Thank you for expressing an interest in the M3 Study.

If you are interested in taking part in this study, this website is for you. Here you will find details of the study, including the criteria used by the research team to see if this study is suitable for you.

Scroll down for more information

On this website you can:

  • Learn more about the M3 Study

  • Find out if you meet some basic criteria to take part

  • Discover what is expected from people who agree to take part

  • Contact your local centre to find out more about the study

What is the M3 Study?

The M3 Study will test a new type of care that has been specifically designed for young adults (aged 16 – 45 years) with type 2 diabetes, focussing on the things that matter most to them, and making sure that their care is tailored to their needs.

Further information about the study and why it is important:

Type 2 diabetes is becoming more common, and adults are getting it at younger ages. This is called ‘early-onset adult type 2 diabetes’. This is worrying because heart, kidney, and other problems related to diabetes can happen at an earlier age.

People might also find it more difficult to do every-day activities that are important to them, feel more anxious or depressed, and may need to use healthcare services more often.

Healthcare for younger adults with diabetes is currently based on what works for people who are much older. This is because more research is required on the needs of younger people.

Taking part in this clinical study may improve future treatment options for young adults living with type 2 diabetes.

You may be able to take part if:

  • You are between 16 – 45 years of age

  • You are currently living with type 2 diabetes

  • You were diagnosed with type 2 diabetes before your 40th birthday

What to expect if you join the study:

We are doing this study to test a new type of care that has been specifically designed for young adults with type 2 diabetes.

If you are eligible and join the study, you will either receive the new type of care (M3), or will continue to receive your usual standard care. We use a special computer system to decide which treatment you get. Your chance of getting the M3 care or usual standard care is the same, but neither you, nor the research team, can pick this for you.

For both treatment groups, the study will last for 2 years and will require 4-6 clinic visits. The visits will be with the study doctor or study staff and you will have blood samples taken at some of the clinic visits along with some questionnaires and other health assessments.

Participation in the study is voluntary. If you decide to take part, you are free to change your mind at any point without giving a reason and without your on-going care being affected. If you have any further questions about the study and what it involves, please get in contact with us using the details at the bottom of the page

FAQs

Click on the questions below to see the answers

  • This study will see whether the M3 intervention can improve the health of younger adults with type 2 diabetes, and if it is affordable for the NHS.

  • Approximately 246 young adults with type 2 diabetes, across Leicester, Derby and London will take part in this study.

  • This will depend on the type of study you are involved in. Please reach out to us to discuss this further using the contact details at the bottom of the page.

  • You can stop being part of the study at any time, without giving a reason and without your on-going care being affected. If you were receiving the M3 intervention, you will be returned to your usual care. We will keep research information and samples we have already collected up until your point of withdrawal.

  • The total time you will be in this study for is about 2 years. This includes 4-6 clinic visits over a 2 year period.

  • All participants will be reimbursed for their time and travel expenses for clinic visits (including taxi, train or bus journeys).

    You will need to provide us with a receipt of your journey to be reimbursed. You may also receive up to £250 for your participation in the study in recognition of your time commitment. You will receive £50 per visit for visits 1, 2, and 3, and £100 for visit 4.

  • The study is funded by the National Institute for Health and Care Research under its Programme Grants for Applied Research and is sponsored by the University of Leicester.

Contact Information:

If you have any further questions then please feel free to call us on 0116 2584251, or email us on m3research@uhl-tr.nhs.uk